CC
DGX icon

Corton Capital’s Quest Diagnostics DGX Stock Holding History

Corton Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,313
Closed -$319K – 540
2023
Q4 		$319K Buy
+2,313
New +$304K 0.1% 300
2023
Q3 		– Sell
-1,689
Closed -$237K – 445
2023
Q2 		$237K Buy
+1,689
New +$233K 0.11% 277
2022
Q2 		– Sell
-2,464
Closed -$337K – 375
2022
Q1 		$337K Buy
+2,464
New +$343K 0.15% 198

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Corton Capital's DGX Position: Q1 2024 in Review

Corton Capital sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 2,313 shares — an estimated $319K sold.

Corton Capital first reported a position in DGX in Q1 2022 and held it in 3 quarters. The position peaked at $337K in Q1 2022. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

  • Corton Capital reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
  • Corton Capital sold 2,313 Quest Diagnostics shares in Q1 2024, an estimated $319K.
  • Corton Capital first reported a position in Quest Diagnostics in Q1 2022 and held it in 3 quarters.
  • Corton Capital's Quest Diagnostics position peaked at $337K in Q1 2022.
  • 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Corton Capital's 13F filing for Q1 2024, filed 15 May 2024.